GPNX
NOTIFICATION PROCESSED BY IB
10/24/2022
Back to search
Official data from USPTO
TPC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
10/24/2022
Trademark type
Word
Nice classes
5
Filing date
08/04/2021
Registration date
08/23/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
08/23/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
BUTLER, MIDGE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
SAEGUSA & PARTNERS
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; diagnostic reagents for medical purposes; chemical preparations for pharmaceutical or medical purposesfor tumor or cancer; diagnostic preparations for medical purposes
Publications
History of USPTO decisions and trademark events.
13 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2022
FIMP
FINAL DISPOSITION PROCESSED
10/05/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
09/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
06/07/2022
NPUB
NOTICE OF PUBLICATION
05/18/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2022
DOCK
ASSIGNED TO EXAMINER
05/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/01/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/22/2021
Continuous trademark protection
Get notified about every new filing that threatens TPC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.